Last November’s election ushered in a new administration, a new Congress, and a new political agenda. One of the Trump ...

Large Indian drug manufacturers experienced relief as President Trump's administration decided against imposing expected ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

“This agreement is a long-term investment into securing the future of botanical drug innovation,” said Uttam Patil, Ph.D., Chief Executive Officer of ABVC. “By locking in upstream resources in Asia, ...

Tasman Therapeutics, Inc. (Tasman) has announced plans to raise $175 million in Series A funding to support the late-stage clinical development and eventual commercialization of R-107. This innovative ...

New Delhi: In line with the wholesale price index (WPI) at 1.74028% for the year 2024 over 2023, through a recent notification, the drug price regulator, National Pharmaceutical Pricing Authority ...

One of the great things about equity markets is that you don't need a fortune to get started. Though strong companies that ...

A recent study on Huonslab’s Hydiffuze technology has found that the pharmaceutical product demonstrated enhanced bioavailability of subcutaneous infliximab has been selected as a poster presentation ...

LBB Specialties, a leader in specialty chemicals and ingredient distribution in North America , is pleased to announce a new ...

Generic medicines may cost higher in the US if Indian pharma companies decide to pass on the 26 per cent tariff in their ...

Fette Compacting is on a successful path and presents itself confidently as a strategic partner for the pharmaceutical and ...